Last reviewed · How we verify

NCT04945512

Efficacy of Epidural Analgesia in Lower Extremity Osteosarcoma

Status unknown NA Last updated 9 November 2021
What this trial tests

NA trial testing Epidural Analgesia in Osteosarcoma in 28 participants. Status unknown.

Timeline
7 November 2021
Primary endpoint
20 August 2022
20 September 2022

Quick facts

Lead sponsorIstanbul University
PhaseNA
StatusStatus unknown
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingnone
Primary purposetreatment
Enrollment28
Start date7 November 2021
Primary completion20 August 2022
Estimated completion20 September 2022
Sites1 location across Turkey (Türkiye)

Drugs / interventions tested

Conditions studied

Sponsor

Istanbul University

Who can join

Adults 18 to 80, any sex, with Osteosarcoma or Analgesia. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

In this study, the investigators aim to reduce complications in orthopedic malignancy surgeries and to increase the quality of life of patients who will be operated on.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of Epidural Analgesia

Trials testing the same drug.

Other recruiting trials for Osteosarcoma

Currently open trials in the same condition.

Other Istanbul University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04945512.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing